Stocks / NASDAQ / Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

Our Opinion

Galectin Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company stated about its product¬†GR-MD-02 in the following article that, “Our data show that GR-MD-02 has a powerful therapeutic effect on liver fibrosis as shown in several relevant animal models. ” Read the full article.

Company Description

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA. [Source: MarketWatch]

Company Website: